Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 5.2% in the morning session after the company and other cannabis stocks rose after a House committee approved a bill that includes a provision protecting state-legal medical marijuana programs from federal interference.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 4.6% in the morning session after reports revealed Department of Justice canceled pending cannabis rules. This regulatory setback adds to a host of challenges for the cannabis producer. The company is already under pressure to meet Nasdaq's listing standards, which require a minimum share price that Tilray has struggled to maintain. To address this, the company has been exploring options like a reverse stock split. Compounding these issues, Tilray reported a significant net income loss of approximately $1.27 billion for the quarter ended May 31, 2025, highlighting its difficult financial position in a competitive market.
What a fantastic six months it’s been for Tilray. Shares of the company have skyrocketed 75.5%, hitting $1.07. This performance may have investors wondering how to approach the situation.
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
LITTLETON, Colo., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a craft brewery owned by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), is proud to announce it has received the Silver Certification from the Colorado Green Business Network (CGBN), recognizing the brewery’s ongoing commitment to sustainability and environmental stewardship across its operations.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 7.2% in the afternoon session after investors weighed data showing a high level of short interest in the company, suggesting negative market sentiment. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. A high short interest can indicate that investors are pessimistic about a stock's future prospects. According to a recent report, Tilray's short percent of float has declined by 20.06%.
BRECKENRIDGE, Colo., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), has announced a strategic change in its California distribution approach, appointing Winebow, a respected national partner, to manage distribution responsibilities within the state.
Bold New Broncos-Inspired Whiskeys and Vodka Seltzers Commemorate the 2015 World Championship and Solidify Breckenridge as the Official Bourbon and Vodka of the Denver Broncos
Researchers have found that people who begin using cannabis to cope with depression, anxiety, or pain are more likely to experience paranoia compared to those who use it casually for fun or curiosity.
Researchers have found that people who begin using cannabis to cope with depression, anxiety, or pain are more likely to experience paranoia compared to those who use it casually for fun or curiosity.
A number of stocks fell in the afternoon session after the major indices continued to retreat (Nasdaq -1.5%, S&P 500 -1.2%) amid profit-taking and renewed concerns about tariffs.
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts.
But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.
Tilray, with core cannabis ops in Canada, has a diversified footprint in the U.S. due to federal restrictions that exclude TLC, but has positionied itself for future expansion.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 5.7% in the afternoon session after a recent rally in cannabis stocks, fueled by hopes of federal marijuana rescheduling in the U.S., reversed course.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 5.5% in the afternoon session after the company announced the launch of three new EU-GMP certified medical cannabis strains in Germany.
NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that it received written notice from the Nasdaq Stock Market, LLC (“Nasdaq”) confirming that Tilray is again in compliance with Nasdaq’s minimum bid price requirement set forth in 5450(a)(1) of the Nasdaq Listing Rules. To achieve this, the Company’s shares were required to close at $1.00 or higher for at least 10 consecutive trading days. According to Nasdaq’s notice, Tilray maintained a closing bid price of at least $1.00 for 10 consecutive trading days from August 13, 2025 to August 26, 2025, thereby meeting the minimum bid price requirement. As a result, Nasdaq has closed the matter.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 5.8% in the morning session after investors took profits after a significant rally in the previous session.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 3.2% in the morning session after the cannabis sector experienced a broad rally fueled by growing optimism for U.S. cannabis reform, further bolstered by a bullish update from a Jefferies analyst.
